title: Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer.
authors.affiliation: Department of Surgery, University of Regensburg, Regensburg, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Iesalnieks
authors.forename: S
authors.initials: S
authors.lastname: Tange
authors.forename: M N
authors.initials: MN
authors.lastname: Scherer
authors.forename: C
authors.initials: C
authors.lastname: Graeb
authors.forename: E
authors.initials: E
authors.lastname: Frank
authors.forename: K W
authors.initials: KW
authors.lastname: Jauch
authors.forename: E K
authors.initials: EK
authors.lastname: Geissler
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control*; D002460:Cell Line; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008113:Liver Neoplasms / Q000517:prevention & control*; D016031:Liver Transplantation / Q000502:physiology*; D017239:Paclitaxel / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D051381:Rats; D011912:Rats, Inbred ACI; D011915:Rats, Inbred BUF; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous / Q000502:physiology
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel